TrialAnnals of transplantation2021

Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial.

Arman Faravardeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.